BrightMatter Guide, Product Number SYN-0026, Versions: 1.5.0, 1.5.1 and 1.5.2 Product Usage: ...

FDA Device Recall #Z-0470-2019 — Class I — October 9, 2018

Recall Summary

Recall Number Z-0470-2019
Classification Class I — Serious risk
Date Initiated October 9, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Synaptive Medical Inc
Location Toronto, N/A
Product Type Devices
Quantity 37 units

Product Description

BrightMatter Guide, Product Number SYN-0026, Versions: 1.5.0, 1.5.1 and 1.5.2 Product Usage: BrightMatter Guide can navigate a third-party port (NICO BrainPath device) by attaching Synaptive s custom Tracking Array to the port directly. As the BrainPath is navigable in two configurations (sheath only / sheath and obturator), the tip of the obturator is represented in the software with a tip extension beyond the bottom of the sheath. Note sheath and cannula are used interchangeably in this document.

Reason for Recall

This recall has been initiated due to a software defect found in the Guide System software when used with NICO BrainPath ports under certain circumstances. When one trajectory is set with a blue port and another trajectory is set with a gold port, the software defect is triggered when the user switches between these trajectories during a surgical procedure.

Distribution Pattern

Worldwide - US Nationwide Distribution and the country of Canada

Lot / Code Information

Serial Numbers: 0063HJ5Y062 00635F48562 00635GTYK32 00638HTZK32 0063G6DRM12 0063CPBRM12 006395Q2Z52 0063J9BD062 00634X19562 0063GN0B562 00637BP9562 0063JTDW462 00638J89562 006360JV462 0063F1Q2Z52 0063FGWYK32 006384WYK32 00635YH8562 0063C2SKH72 00635NWPK12 0063DKWYK32 006358Q2Z52 0063HM0B562 0063DZPGP12 00634BBD062 00636L48562 0063DD8GP12 0063HCZ1Z52 006318XYK32 0003CZDRLC2 0063GLD6562 0063HRZYK32 006317B8562 006348M5562 0063HGTYK32 0063FHXY062 00634DBD062

Other Recalls from Synaptive Medical Inc

Recall # Classification Product Date
Z-1955-2021 Class II Synaptive Trackable Suction Set Standard and Ma... Apr 23, 2021
Z-1758-2020 Class II ClearCanvas RIS/PACS Feb 26, 2020
Z-1759-2020 Class II Synaptive ImageDrive Clinical Feb 26, 2020

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.